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A new synthetic biology approach allows
transfer of an entire metabolic pathway
from a medicinal plant to a biomass crop
Paulina Fuentes, Fei Zhou†, Alexander Erban, Daniel Karcher, Joachim Kopka,
Ralph Bock*
Max-Planck-Institut fu¨r Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany
Abstract Artemisinin-based therapies are the only effective treatment for malaria, the most
devastating disease in human history. To meet the growing demand for artemisinin and make it
accessible to the poorest, an inexpensive and rapidly scalable production platform is urgently
needed. Here we have developed a new synthetic biology approach, combinatorial
supertransformation of transplastomic recipient lines (COSTREL), and applied it to introduce the
complete pathway for artemisinic acid, the precursor of artemisinin, into the high-biomass crop
tobacco. We first introduced the core pathway of artemisinic acid biosynthesis into the chloroplast
genome. The transplastomic plants were then combinatorially supertransformed with cassettes for
all additional enzymes known to affect flux through the artemisinin pathway. By screening large
populations of COSTREL lines, we isolated plants that produce more than 120 milligram artemisinic
acid per kilogram biomass. Our work provides an efficient strategy for engineering complex
biochemical pathways into plants and optimizing the metabolic output.
DOI: 10.7554/eLife.13664.001
Introduction
Artemisinin, a C15 isoprenoid (sesquiterpene) naturally produced in the wild plant Artemisia annua
(sweet wormwood, native to temperate Asia), is the main ingredient of artemisinin combination ther-
apies (ACTs), currently the only effective cure of malaria (Okell et al., 2014). As ACTs are the main-
stay of malaria treatment and no alternative to artemisinin derivatives is expected to enter the
market in the foreseeable future, there is a steadily increasing demand for ACTs which reached
nearly 400 million treatment courses in 2013 (http://www.who.int/malaria/publications/world_
malaria_report_2014). The mechanism of action of artemisinin on the malaria parasites Plasmodium
falciparium and P. vivax is not entirely clear, but it is generally believed that the reactive endoperox-
ide bridge present in the molecule (Figure 1) is responsible for its medicinal properties. In addition
to their antimalarial activity, artemisinin and its derivatives are currently also considered as promising
anti-cancer, antiviral and anti-inflammatory agents (e.g., Willoughby et al., 2009). In A. annua, arte-
misinin is produced in the cytosol of the glandular trichomes of leaves and flowers (Tang et al.,
2014). The biosynthesis initiates with the conversion of the isoprenoid building blocks IPP and
DMAPP into farnesyl pyrophosphate (FPP) which is then converted into amorpha-4,11-diene by
amorphadiene synthase (ADS), the enzyme catalyzing the first committed step of the pathway (Fig-
ure 1). Amorpha-4,11-diene is a volatile compound that is oxidized to artemisinic alcohol and subse-
quently to artemisinic aldehyde by the cytochrome P450 monooxygenase CYP71AV1 (CYP) and its
redox partner, the cytochrome P450 reductase (CPR). Artemisinic aldehyde is then further oxidized
to artemisinic acid by the same enzyme pair, or alternatively, is reduced to dihydroartemisinic alde-
hyde by the double bond reductase 2 (DBR2; Figure 1; Zhang et al., 2008). Artemisinic acid can be
efficiently and cheaply converted to artemisinin by chemical means (Paddon et al., 2013;
Fuentes et al. eLife 2016;5:e13664. DOI: 10.7554/eLife.13664 1 of 26
RESEARCH ARTICLE
Kopetzki et al., 2013) and, therefore, represents a high-value precursor for the industrial production
of artemisinin-based pharmaceuticals (Paddon and Keasling, 2014).
In view of the great medicinal value of artemisinic compounds, their low accumulation levels in A.
annua and the unstable supply of the plant, enormous efforts have been undertaken to produce
artemisinic compounds synthetically or in heterologous biological systems. Currently, the semisyn-
thetic synthesis in yeast (Paddon et al., 2013) represents the most efficient heterologous production
system for artemisinic acid, the immediate precursor of artemisinin (Figure 1). However, the produc-
tion costs are still high and ACTs remain unaffordable to many people in the tropical and subtropical
regions of Africa and Asia that are most severely afflicted with malaria. Since production in yeast
requires large volumes of costly synthetic culture media and large-capacity bioreactors run under
sterile conditions, production in plants can potentially provide a much cheaper, renewable and easily
scalable source of artemisinic acid. Although the production of artemisinic compounds at low levels
has been shown to be feasible in heterologous plant systems (Wu et al., 2006; van Herpen et al.,
2010; Zhang et al., 2011; Farhi et al., 2011), the development of an efficient production system for
the drug precursor artemisinic acid has not been achieved.
Here we have pursued a novel synthetic biology approach towards high-level production of arte-
misinic acid in chloroplasts of tobacco (Nicotiana tabacum), a fast-growing crop that produces high
amounts of biomass at very low cost. We show that by implementing the core pathway in the chloro-
plast and subsequently selecting for optimum combinations and expression levels of additional
eLife digest Malaria is by far the most devastating tropical disease in the world. It affects
hundreds of millions of people – mainly in Africa and Asia – with almost half a million deaths every
year. The most effective therapies against malaria all include the drug artemisinin, which is naturally
found in an Asian plant called Artemisia annua. Unfortunately, the artemisinin content of A. annua
plants is relatively low and the demand for this drug outstrips the supply of the plant. The costly
production process makes artemisinin-based treatments inaccessible to many of the people in the
most badly affected regions, and so researchers have been trying to find new ways to produce this
drug.
Genetically modifying crop plants, such as tobacco, to produce artemisinin or related compounds
could potentially provide a more sustainable and cheaper source of the drug. Inside plant cells, a
structure called the nucleus contains DNA that encodes most of a plant’s genes, but compartments
called mitochondria and chloroplasts also contain some DNA. Existing methods to genetically
modify plants are able to insert a few genes into either the nucleus or the chloroplasts at a time.
However, the production of artemisinin in A. annua involves many different genes that act at
different stages of the process, and the precise roles played by many of them remain unclear.
Fuentes et al. developed a new approach to insert many of the A. annua genes involved in
artemisinin production into tobacco plants at the same time, instead of one-by-one. The new
method, referred to as COSTREL, takes advantage of the researchers’ ability to insert new genes
into both the nucleus and the chloroplast of the tobacco plants. In the first step, Fuentes et al.
inserted a core set of genes that are essential to make artemisinin into the chloroplast. This enabled
the plants to produce a molecule called artemisinic acid, which the researchers can extract from the
plants and convert into artemisinin by simple chemical reactions.
After testing different arrangements of the genes in the chloroplast, the plant line that had the
highest levels of artemisinic acid was used to introduce a set of “accessory” genes into the nuclear
DNA. These accessory genes are not strictly required to make the drug, but they help to regulate
the process in a largely unknown manner. The experiments generated hundreds of genetically
modified plant lines that each have different combinations of the accessory genes. Fuentes et al.
examined these lines and were able to identify plants that could produce large amounts of
artemisinic acid. Therefore, these findings lay the foundations for a cheap way to produce this life-
saving drug in tobacco. In the future, the COSTREL method developed by Fuentes et al. could also
be used to genetically engineer other complex biochemical processes into plants.
DOI: 10.7554/eLife.13664.002
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pathway enzymes from a large population of combinatorially supertransformed transplastomic lines,
artemisinic acid can be produced in tobacco leaves to levels of more than 120 mg/kg fresh weight.
Results
Expression of the core pathway for artemisinic acid synthesis from the
plastid genome
The core enzymes to synthesize artemisinic acid are FPS, ADS, CYP and CPR (Figure 1). Accessory
enzymes (indicated in red in Figure 1) and additional enzymes facilitating more efficient biosynthesis
of artemisinin are CYB5, ADH1, ALDH1 and DBR2. We first implemented the canonical pathway
from FPP to artemisinic acid in tobacco chloroplasts using stable plastid genome transformation
Figure 1. Metabolic pathway of artemisinin biosynthesis. The canonical pathway of artemisinin synthesis starts with
the conversion of IPP/DMAPP (C5 isoprenoids produced by the MVA pathway in the cytosol or the MEP pathway in
the chloroplast) into farnesyl pyrophosphate (FPP), catalyzed by farnesyl pyrophosphate synthase (FPS). Amorpha-
4,11-diene synthase (ADS) converts FPP into amorpha-4,11-diene in the first committed step of the pathway.
Amorpha-4,11-diene is then successively oxidized to artemisinic alcohol, artemisinic aldehyde and artemisinic acid
by the cytochrome P450 monooxygenase CYP71AV1 (CYP) and its redox partner, the cytochrome P450 reductase
(CPR). In A. annua, artemisinic aldehyde is converted to dihydroartemisinic aldehyde by DBR2, and then to
dihydroartemisinic acid by ALDH1. Artemisinin is generated by the spontaneous oxidation of dihydroartemisinic
acid in planta, and can be produced by chemical conversion of artemisinic acid in vitro. Enzymes depicted in red
improve the efficiency of different oxidation steps in yeast (Paddon et al., 2013; Paddon and Keasling, 2014).
See text for details.
DOI: 10.7554/eLife.13664.003
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(Svab and Maliga, 1993; Bock, 2015). To this end, we designed a number of synthetic operons
(Zhou et al., 2007; Lu et al., 2013) that combine the genes for the four core enzymes (FPS, ADS,
CYP and CPR; Figure 1) in different arrangements and under the control of different expression sig-
nals (Figure 2A). Four synthetic artemisinic acid operon constructs (pAO1-4) were built and intro-
duced into the chloroplast (plastid) genome of tobacco plants by particle gun-mediated
transformation. Chloroplast-transformed (transplastomic) lines were selected on regeneration
medium with spectinomycin and purified to homoplasmy by additional rounds of selection and
regeneration (Svab and Maliga, 1993; Bock, 2015). Restriction fragment length polymorphism
(RFLP) analysis verified integration of the synthetic operon constructs into the plastid genome by
homologous recombination and successful elimination of all wild-type copies of the highly polyploid
chloroplast genome (Figure 2B). Homoplasmy of the transplastomic lines was additionally verified
by seed assays that confirmed lack of segregation of the spectinomycin resistance and uniparentally
maternal inheritance (Figure 2C).
All homoplasmic transplastomic lines grew autotrophically under greenhouse conditions and pro-
duced viable seeds. However, transplastomic lines obtained with constructs pAO1 and pAO3
(Figure 2A) displayed a slightly pale-green phenotype and a subtle growth delay at the juvenile
stage (Figure 3A; Figure 3—figure supplement 1). This phenotype could be due to toxicity of arte-
misinic metabolites produced in these plants (Bharati et al., 2012) or, alternatively, depletion of iso-
prenoid precursors from other metabolic pathways in the cell, such as carotenoid and chlorophyll
biosyntheses. Measurement of chlorophylls and carotenoids confirmed that, indeed, both pigment
classes are significantly reduced in plants exhibiting the mild phenotype (Figure 3—figure supple-
ments 1 and 2). Metabolite profiling (see Materials and Methods) of the transplastomic lines
revealed that all lines accumulated the volatile artemisinic acid precursor amorpha-4,11-diene and its
first oxidation product artemisinic alcohol (Figure 1; Figure 3). Interestingly, amorpha-4,11-diene
accumulated to lower levels in the lines displaying the subtle phenotype, whereas artemisinic alcohol
was detected in similar amounts in all transplastomic plants. Accumulation of artemisinic acid corre-
lated with the altered phenotype in Nt-AO1-1 and Nt-AO3-1, suggesting that a more efficient con-
version of amorpha-4,11-diene to downstream metabolites could be the cause of the phenotype.
This hypothesis gained support from the analysis of a series of developmental stages and leaf ages
which revealed that, while in Nt-AO2 plants, artemisinic acid accumulates only in mature leaves of
young and flowering plants, it accumulates throughout development in Nt-AO3 plants. These analy-
ses also confirmed the inverse relationship between artemisinic acid and amorpha-4,11-diene accu-
mulation (Figure 4A–C).
To identify the molecular basis of the striking metabolic differences between the different operon
constructs, a series of northern blot experiments was conducted. In view of the commonalities of the
Nt-AO2 and Nt-AO4 plants versus the Nt-AO1 and Nt-AO3 plants, it seemed reasonable to assume
that the relative orientation of the two operons (Figure 2A) is causally responsible for the different
visual and metabolic phenotypes. When the expression of the four transgenes was assayed, a strik-
ing difference was observed in the CYP/CPR expression ratio in that high artemisinic acid accumula-
tion correlated with a high CYP/CPR expression ratio in Nt-AO3 plants (Figure 4D–G; Figure 4—
figure supplement 1). In nature, CYPs are often found in excess to their CPR counterparts, with
ratios of 10–100:1 or higher (reviewed, e.g., in Guengerich, 2002). Even though there is currently no
consensus explanation for this observation, it is known that CPRs can activate molecular oxygen,
thereby producing superoxide radicals and wasting redox capacity of the cell (Manoj et al., 2010).
A high CYP/CPR ratio would prevent this CPR-mediated toxicity and result in a more efficient use of
the redox power of the cell for artemisinic acid synthesis, as observed in our Nt-AO1 and Nt-AO3
transplastomic lines. This explanation is also in agreement with published data on transcript accumu-
lation and protein abundance for these two enzymes in A. annua. While the levels of the CPR tran-
script and the CPR protein remain constant during development of the plant and in different organs,
the transcript and protein levels of CYP increase in the developmental stages and organs where arte-
misinin synthesis is induced (Olofsson et al., 2011; Zeng et al., 2008). Especially the final oxidation
step from artemisinic aldehyde to artemisinic acid appears to require an effective monooxygenase
(Ting et al., 2013), suggesting that the higher levels of artemisinic acid in our transplastomic Nt-
AO1 and Nt-AO3 lines are most likely related to their higher CYP/CPR expression ratio. However,
determination of the CYP and CPR protein accumulation levels (and enzyme activities) would be
Fuentes et al. eLife 2016;5:e13664. DOI: 10.7554/eLife.13664 4 of 26
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Figure 2. Implementation of the canonical pathway of artemisinic acid biosynthesis in chloroplasts. Synthetic codon-optimized genes for the four
enzymes required to produce artemisinic acid (Figure 1) were introduced into the tobacco plastid genome by stable genetic transformation with four
Figure 2 continued on next page
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necessary to precisely assess these ratios and ultimately confirm their impact on metabolite conver-
sion in the pathway.
Pathway optimization by combinatorial supertransformation
Having successfully implemented the canonical pathway of artemisinic acid synthesis into the chloro-
plast of tobacco plants, we next sought to maximize artemisinic acid production. In our best-per-
forming transplastomic plants (Nt-AO3), artemisinic acid accumulation reached a maximum of 2–4
mg/kg fresh weight (FW), equivalent to approximately 20–40 mg/kg dry weight (DW; or 0.002–
0.004% DW), a level significantly lower than artemisinin accumulation in A. annua (varying between
0.01 and 1% DW; Liu et al., 2011; Bryant et al., 2015). Recently, a number of accessory A. annua
enzymes have been identified that enhance the flux through the pathway, including a cytochrome b5
(CYB5) that promotes electron transfer to P450 monooxygenases (Schenkman and Jansson, 2003),
a new alcohol dehydrogenase (ADH1) that improves the oxidation of artemisinic alcohol to artemi-
sinic aldehyde (Paddon et al., 2013) and an aldehyde dehydrogenase (ALDH1) that catalyzes the
conversion of dihydroartemisinic aldehyde into dihydroartemisinic acid and, in yeast, also enhances
the conversion of artemisinic aldehyde into artemisinic acid (Paddon et al., 2013; Figure 1). We also
considered two additional enzymes: The double bond reductase 2 (DBR2) from A. annua introduces
a branch point into the pathway by reducing artemisinic aldehyde to dihydroartemisinic aldehyde
(Zhang et al., 2008) and, therefore, potentially can lead to the synthesis of artemisinin (Figure 1).
Finally, the 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) from the cyanobacterium Syne-
chocystis, a key regulatory enzyme in the MEP pathway of isoprenoid biosynthesis, was selected
because its expression may improve precursor availability (Figure 1). Since the quantitative contribu-
tions of these enzyme activities to artemisinic acid biosynthesis are not well understood and, more-
over, the optimum enzyme activities required to mediate maximum flux through the pathway are
unknown, we decided to pursue a combinatorial supertransformation approach. Combinatorial trans-
formation involves the mixing of multiple single-gene transformation constructs and their biolistic
co-transformation followed by large-scale screening of many transgenic lines by their metabolic (or
other) phenotypes (Zhu et al., 2008; Naqvi et al., 2009). Individual transgenic lines generated by
this approach differ in the transgene combination they harbor as well as in transgene copy numbers
and expression levels, thus facilitating selection of optimized genotypes that condition the desired
metabolic output (Naqvi et al., 2009). We applied combinatorial nuclear transformation to our
transplastomic Nt-AO2-1 (high accumulation of amorpha-4,11-diene but low levels of artemisinic
acid) and Nt-AO3-1 (low accumulation of amorpha-4,11-diene and high accumulation of artemisinic
acid) lines, assuming that artemisinic acid production can be substantially increased by identifying
the optimum combination and expression levels of the additional pathway enzymes. Combinatorial
supertransformation of transplastomic lines encoding a canonical metabolic pathway with a plasmid
cocktail containing additional and/or accessory pathway enzymes represents a new approach in
Figure 2 continued
different synthetic operon constructs (pAO1-4). The constructs differ in gene arrangement and in the translation signals that drive synthesis of the key
pathway enzyme (ADS) catalyzing the first committed step. (A) Physical map of the plastid genome region (ptDNA) used for integration of the synthetic
artemisinic acid operons and maps of the transgenic loci in the generated transplastomic tobacco lines (Nt-AO1-4). The artemisinic acid operon genes
are depicted as light blue boxes. Chloroplast promoters and terminators are shown in green, the aadA selectable marker gene for chloroplast
transformation is represented as a white box, and genes in flanking plastid sequences used for transgene targeting via homologous recombination are
in black. Genes above the line are transcribed from left to right, genes below the line are transcribed in the opposite direction. The four transgenes are
arranged in two dicistronic operons. FPS and CYP are driven by the Chlamydomonas reinhardtii plastid ribosomal RNA operon promoter (Cr Prrn) and
the g10 leader sequence from phage T7 (T7 Lg10). The second operon containing ADS and CPR is driven by the C. reinhardtii psbA promoter (Cr
PpsbA) and either the T7 Lg10 or the psbA leader sequence from C. reinhardtii (Cr LpsbA). This operon is arranged either in sense and downstream of
the first operon (AO1, 3) or in antisense, downstream of the aadA cassette (AO2, 4). The genes in each operon are separated by an intercistronic
expression element (IEE) conferring intercistronic RNA processing and, in this way, enhancing expression of downstream cistrons of the operon
(Zhou et al., 2007; Drechsel and Bock, 2010). The BamHI restriction sites used in RFLP analyses and the expected fragment sizes are indicated. The
location of the hybridization probe is shown as a black bar. Cr: C. reinhardtii; Nt: N. tabacum; T7: bacteriophage T7; P: promoter; L: leader sequence; T:
terminator; SD: Shine-Dalgarno sequence. (B) RFLP analysis of transplastomic plants. Two independently isolated transplastomic lines are shown for
constructs pAO1-3 and one for pAO4. (C) Seed assays confirming the homoplasmic state of the transplastomic plants. Seeds were germinated on
medium containing 500 mg/L spectinomycin (Nt-AO2-1, Nt-AO3-1, Nt-wt) or antibiotic-free medium (Nt-wt).
DOI: 10.7554/eLife.13664.004
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Figure 3. Phenotype of transplastomic tobacco plants and accumulation of artemisinic compounds. (A) Transplastomic lines Nt-AO1-1 and Nt-AO3-1
display a slightly pale and growth-delayed phenotype at the juvenile stage. WAT: weeks after transfer from tissue culture to soil; scale bars: 10 cm. (B)
Amorpha-4,11-diene is synthesized in all transplastomic lines, but accumulates to lower levels in the lines displaying an altered phenotype (purple bars).
(C) Artemisinic alcohol is detected in similar amounts in all transplastomic plants. (D) Accumulation of artemisinic acid correlates with the altered
phenotype of Nt-AO1-1 and Nt-AO3-1. Relative accumulation of amorpha-4,11-diene was profiled by GC-MS analysis of volatile organic compounds
(VOCs). Relative accumulation of the sum of free and conjugated artemisinic alcohol and artemisinic acid were determined by GC-MS analysis of the
soluble metabolite fraction after saponification (see Materials and methods; Figures 6 and 7). In agreement with previous reports (van Herpen et al.,
2010), these compounds were found to be present mainly as conjugates. Expanding leaves of 5–6 plants per line were used for each measurement.
Error bars represent the SD. Different letters above the bars indicate significant differences as determined by One-way ANOVA (p<0.001) and the
Holm-Sidak post-hoc test.
DOI: 10.7554/eLife.13664.005
The following figure supplements are available for figure 3:
Figure supplement 1. Phenotypes of Nt-AO2-1 and Nt-AO3-1 plants throughout development.
DOI: 10.7554/eLife.13664.006
Figure supplement 2. Isoprenoids levels throughout development in wild-type Nicotiana tabacum plants (Nt-wt) and the transplastomic lines Nt-AO2-1
and Nt-AO3-1.
DOI: 10.7554/eLife.13664.007
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Figure 4. Production of artemisinic acid is maintained throughout plant development and correlates with a high CYP/CPR expression ratio. Artemisinic
compounds and expression levels of the transgenes were measured in young (stage 1), flowering (stage 2) and old plants (stage 3; see Figure 3—
Figure 4 continued on next page
Fuentes et al. eLife 2016;5:e13664. DOI: 10.7554/eLife.13664 8 of 26
Research article Biochemistry Plant biology
synthetic biology that we refer to as COSTREL (for COmbinatorial Supertransformation of Transplas-
tomic REcipient Lines).
Genes for the five candidate enzymes (CYB5, ADH1, ALDH1, DBR2, DXR) were cloned into indi-
vidual expression cassettes, the resulting plasmids were mixed and co-bombarded with a kanamycin
resistance gene into the nuclear genomes of transplastomic Nt-AO2-1 and Nt-AO3-1 plants. 612
kanamycin-resistant shoots (Nt-AO-CS lines) were generated by supertransformation of the trans-
plastomic recipient lines Nt-AO2-1 and Nt-AO3-1. After rooting in kanamycin-containing medium,
512 plantlets were transferred to soil and grown to maturity under standard greenhouse conditions.
At the onset of flowering, a fully expanded leaf was harvested for preliminary profiling of artemisinic
acid and its precursors by GC-MS (see Materials and Methods). Based on growth, phenotype and
fertility of the plants, 199 COSTREL lines were selected for metabolic screening of artemisinic com-
pounds: 79 Nt-AO2-CS and 120 Nt-AO3-CS lines (Figure 5—source data 1). The various lines dis-
played great variation with respect to the accumulation levels of the compounds assayed (amorpha-
4,11-diene, artemisinic alcohol, dihydroartemisinic alcohol, dihydroartemisinic acid and artemisinic
acid). Importantly, COSTREL lines could be identified that contained strongly increased levels of the
drug precursor artemisinic acid (Figure 5—source data 1).
In combinatorial transformation, all transgenes that simultaneously enter the nucleus of the recipi-
ent cell usually integrate into the same genomic locus (most likely into a transient DNA double-
strand break), and therefore co-segregate into the next generation (Naqvi et al., 2009). This feature
allowed us to raise a T1 generation of supertransformed lines from seeds and repeat the metabolite
profiling with T1 leaf material grown under highly standardized conditions. These analyses confirmed
the results obtained with the T0 plants and revealed that, in the case of the Nt-AO2-CS lines, the
highest increase in artemisinic acid content occurred in line 132 showing a 33-fold increase com-
pared to its transplastomic recipient line Nt-AO2-1, whereas among the Nt-AO3-CS lines, line 180
reached an even 77-fold increase compared to transplastomic line Nt-AO3-1 (Figure 5—source
data 1; Figure 5A). The trait artemisinic acid content was stable across generations, and the highest
producer, line Nt-AO3-CS180, reached levels of 120.4 ± 42 mg per kg FW in the T1 generation.
Identification of limiting steps in artemisinic acid biosynthesis
To obtain insights into pathway regulation and identify bottlenecks in artemisinic acid synthesis, we
investigated correlations between pathway metabolites and between artemisinic acid accumulation
and the set of transgenes expressed in the nucleus of Nt-AO2-CS and Nt-AO3-CS COSTREL lines.
Increased amounts of artemisinic acid in the Nt-AO-CS lines were negatively correlated with the
accumulation of artemisinic alcohol (Figure 5A,B), indicating that the efficiency of oxidation of the
alcohol represents a key bottleneck in the pathway that we alleviated by supertransformation with
the additional pathway genes. Importantly, artemisinic alcohol was reduced to nearly undetectable
Figure 4 continued
figure supplement 1). (A) Amorpha-4,11-diene accumulates to higher levels in line Nt-AO2-1 than in Nt-AO3-1. (B) Artemisinic alcohol is present at
similar levels in early (1) and late stages (3) of development in lines Nt-AO2-1 and Nt-AO3-1, but it is slightly higher in the flowering stage (2) of line Nt-
AO3-1. (C) Artemisinic acid accumulates to high levels during all developmental stages of line Nt-AO3-1, whereas in line Nt-AO2-1, it is detectable only
in mature leaves of young and flowering plants. Relative accumulation of amorpha-4,11-diene and artemisinic alcohol was profiled, the tissue content of
artemisinic acid was quantified using an authenticated reference standard (n = 5–6 plants per line; Figures 6 and 7). The sum of free and conjugated
artemisinic alcohol and artemisinic acid were determined. y: young leaf; i: expanding (intermediate) leaf; m: fully expanded (mature) leaf. Error bars
represent the SD. (D–G) Northern blot analysis of the expression of the four transgenes. Total RNA samples from N. tabacum wild-type (Nt-wt) plants
and the transplastomic lines Nt-AO2-1 and Nt-AO3-1 (at the developmental stages 1–3) were separated in denaturing 1.5% agarose gels, blotted and
hybridized to strand-specific RNA probes. Below each blot, the rRNA-containing region of the ethidium bromide-stained gel prior to blotting is shown
as a control for RNA integrity and equal loading. The Nt-wt sample corresponds to RNA extracted from a fully expanded leaf of a N. tabacum wild-type
plant at developmental stage 2. The smallest labeled band in each blot corresponds to the monocistronic mRNA. Larger bands represent unprocessed
polycistronic precursor transcripts and read-through transcripts (which are common in plastids; e.g., Elghabi et al., 2011; Lu et al., 2013). CYP
transcripts accumulate to higher levels in line Nt-AO3-1, while CPR transcripts accumulate to higher levels in line Nt-AO2-1, resulting in a higher CYP/
CPR expression ratio in line Nt-AO3-1.
DOI: 10.7554/eLife.13664.008
The following figure supplement is available for figure 4:
Figure supplement 1. Quantitation of the expression of CYP and CPR by qRT-PCR analysis.
DOI: 10.7554/eLife.13664.009
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Figure 5. Isolation of combinatorially supertransformed transplastomic lines with a strong increase in artemisinic acid accumulation. Transplastomic
lines Nt-AO2-1 and Nt-AO3-1 were combinatorially supertransformed with genes for additional enzymes of the pathway (Figure 1) to facilitate large-
scale screening for increased artemisinic acid production. (A) Relative artemisinic acid levels (given in response/FW; see Materials and methods) in the
T1 generation of two combinatorially supertransformed lines obtained with transplastomic recipient line Nt-AO2-1 (Nt-AO2-CS) and eight lines
obtained with transplastomic recipient line Nt-AO3-1 (Nt-AO3-CS). An up to 77-fold increase in artemisinic acid was achieved (line Nt-AO3-CS180) in
comparison to recipient line Nt-AO3-1. For a complete list of screened supertransformed lines, see Figure 5—source data 1. (B) Inverse relationship
Figure 5 continued on next page
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levels in the best-performing line Nt-AO3-CS180 suggesting that maximum conversion efficiency has
been achieved (Figure 5B; Figure 5—source data 1). Another significant correlation at the metabo-
lite level was a strong positive correlation between amorpha-4,11-diene and artemisinic alcohol
(Tables 1 and 2) which may be a consequence of the enzymatic limitation downstream of artemisinic
alcohol. By contrast, amorpha-4,11-diene was not significantly correlated with artemisinic acid accu-
mulation. Dihydroartemisinic alcohol (presumably generated by an endogenous enzymatic activity in
tobacco; Ting et al., 2013; Zhang et al., 2011), while accumulating in some lines, showed only a
weak positive correlation with artemisinic acid in the Nt-AO2-CS but not in the Nt-AO3-CS lines (Fig-
ure 5—figure supplement 1; Tables 1 and 2; Figures 6 and 7). Dihydroartemisinic acid, the direct
precursor of artemisinin, was detected only in line Nt-AO3-CS180 in the T0 generation and in lines
Nt-AO3-CS53 and Nt-AO3-CS180 in the T1 generation (Figure 5—source data 1 and Figure 5—fig-
ure supplement 1; Figure 7C), and therefore had to be excluded from the correlation analysis.
To correlate the genotype of the COSTREL lines with their metabolic phenotypes, the transgene
sets present in the nucleus of Nt-AO2-CS and Nt-AO3-CS lines were determined (Figure 5—source
data 1). Statistical analysis revealed that elevated artemisinic acid levels in Nt-AO3-CS lines were
most strongly correlated with the presence of the ALDH1 transgene. Weaker (and statistically not
significant) correlations were observed between high artemisinic acid levels and the presence of dxr
and ADH1, and, in Nt-AO2-CS lines, also the DBR2 and ALDH1 transgenes (Tables 1 and 2). These
results indicate that ALDH1 and dxr are most likely the genes with the greatest impact on the
increase in artemisinic acid content. As transgene presence is not necessarily indicative of transgene
expression, we measured mRNA accumulation in the T1 generation of a selected set of COSTREL
lines by qRT-PCR analyses. The results support the importance of dxr, ADH1, ALDH1 and DBR2 in
boosting artemisinic acid synthesis and revealed that the best-performing line (Nt-AO3-CS180)
expresses dxr, ADH1, ALDH1 and DBR2 to high levels (Figure 5C).
To test whether artemisinic acid accumulation is correlated with a visible phenotype of the plants,
the best-performing COSTREL lines were compared with their transplastomic recipient lines. No sig-
nificant phenotypic differences were observed and even line Nt-AO3-CS180 (that showed the stron-
gest increase in artemisinic acid accumulation; Figure 5A) was nearly indistinguishable from its
transplastomic recipient Nt-AO3-1 (Figure 5D). This suggests that artemisinic acid is not toxic to
plant cells (and that a further increase in artemisinic acid might be achievable). Growth and biomass
measurements confirmed that there are no significant differences between transplastomic line Nt-
AO3-1 and the best-performing COSTREL line Nt-AO3-CS180, and revealed only a small reduction
in total leaf biomass (by on average 13%) of the COSTREL line compared to the wild type (Figure 5—
figure supplement 2).
None of our transplastomic lines and none of the analyzed COSTREL lines accumulated detect-
able levels of artemisinin (see Materials and Methods). This could be because the set of transgenes
introduced into tobacco was insufficient to obtain conversion of artemisinic acid into artemisinin.
However, some of our best-performing COSTREL lines accumulated detectable amounts of
Figure 5 continued
between artemisinic acid accumulation and artemisinic alcohol accumulation in supertransformed lines. Fully expanded leaves of 5–6 plants per line (at
the flowering stage) were used for metabolite profiling. The sum of free and conjugated artemisinic alcohol and artemisinic acid were determined. (C)
qRT-PCR analysis of transgene expression suggests a predominant role of ALDH1 in boosting artemisinic acid synthesis. 2–3 plants per line were
measured, and the expression levels were ranked after One-way ANOVA comparison (p<0.05). Brown color indicates absence of gene expression. (D)
Combinatorially supertransformed lines with a high increase in artemisinic acid (Nt-AO2-CS132 and Nt-AO3-CS180) display a similar phenotype as the
corresponding transplastomic recipient line. WAT: weeks after transfer from tissue culture to soil; scale bars: 10 cm.
DOI: 10.7554/eLife.13664.010
The following source data and figure supplements are available for figure 5:
Source data 1. Metabolic screening (phenotyping) and genotyping of the T0 generation of combinatorially supertransformed Nt-AO-CS lines.
DOI: 10.7554/eLife.13664.011
Figure supplement 1. Amorpha-4,11-diene, dihydroartemisinic alcohol and dihydroartemisinic acid accumulation in the T1 generation of
combinatorially supertransformed plants.
DOI: 10.7554/eLife.13664.012
Figure supplement 2. Measurements of plant height and total leaf biomass of COSTREL line Nt-AO3-CS180 (progeny of four different T1 lines), its
transplastomic progenitor line Nt-AO3-1 and the wild type (wt).
DOI: 10.7554/eLife.13664.013
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dihydroartemisinic acid (Figure 5—source data 1 and Figure 5—figure supplement 1; Figure 7),
the immediate precursor of artemisinin, indicating that DBR2 and ALDH1 can function in plastids.
The chloroplast is likely to produce sufficient amounts of singlet oxygen (which is a regular by-prod-
uct of photosynthetic electron transfer) to facilitate the spontaneous conversion of dihydroartemi-
sinic acid into artemisinin (Kopetzki et al., 2013; Figure 1). An alternative explanation for the lack
of artemisinin accumulation could be that COSTREL lines that produce artemisinin were not recov-
ered, because artemisinin is highly toxic to photosynthetically active cells (Bharati et al., 2012). The
fact that no artemisinin could be detected and only low amounts of dihydroartemisinic acid were
obtained in a few lines, whereas artemisinic acid accumulated to high amounts, may indicate that
future efforts should be focused on maximizing the production of artemisinic acid.
Discussion
In the course of this work, we have developed a new synthetic biology approach that combines chlo-
roplast transformation with combinatorial nuclear transformation and large-scale metabolic screen-
ing of supertransformed plant lines. This strategy enabled the transfer of an entire biochemical
pathway of secondary metabolism from a medicinal plant to a high-biomass crop.
For the foreseeable future, ACTs will remain the most powerful weapon in the world’s battle
against malaria (http://www.who.int/malaria/areas/treatment/overview/en/). When used as an oral
monotherapy, artemisinin can promote the development of resistance in the parasite (Mok et al.,
2015; Straimer et al., 2015; Mbengue et al., 2015) and, therefore, ACTs are based on fixed-dose
co-formulations that combine two different active ingredients in one tablet. Development of an
Table 1. Correlation analysis of artemisinic compounds and transgenes introduced into transplastomic line Nt-AO2-1 by combinatorial
supertransformation. The levels of the artemisinic compounds amorpha-4,11-diene, artemisinic alcohol, dihydroartemisinic alcohol and
artemisinic acid, and the presence of the transgenes dxr, CYB5, ADH1, ALDH1 and DBR2 were correlated using Spearman’s method in
the 39 Nt-AO2-CS lines analyzed by genomic PCR in the T0 generation (see Figure 5—source data 1) using the SPSS software.
Dihydroartemisinic acid was excluded from this analysis, because it was not detectable in any of the Nt-AO2-CS lines. CC: correlation
coefficient. Positive values indicate positive correlations and negative values indicate negative correlations. *: p<0.05; **: p<0.01; N:









acid dxr CYB5 ADH1 ALDH1 DBR2
Amorpha-4,11-
diene
CC 1.000 0.602** 0.147 -0.112 0.067 -0.020 -0.009 -0.015 0.156
N 35 29 13 24 35 35 35 35 35
Art. alcohol CC 0.602** 1.000 -0.557* -0.141 -0.159 -0.165 -0.170 0.013 -0.217
N 29 29 13 24 29 29 29 29 29
Dihydroart. alcohol CC 0.147 -0.557* 1.000 0.642* 0.462 0.248 0.383 0.180 0.496
N 13 13 13 13 13 13 13 13 13
Art. acid CC -0.112 -0.141 0.642* 1.000 0.404 0.159 0.179 0.207 0.317
N 24 24 13 24 24 24 24 24 24
dxr CC 0.067 -0.159 0.462 0.404 1.000 0.643** 0.402* 0.546** 0.578**
N 35 29 13 24 39 39 39 39 39
CYB5 CC -0.020 -0.165 0.248 0.159 0.643** 1.000 0.192 0.507** 0.793**
N 35 29 13 24 39 39 39 39 39
ADH1 CC -0.009 -0.170 0.383 0.179 0.402* 0.192 1.000 0.372* 0.270
N 35 29 13 24 39 39 39 39 39
ALDH1 CC -0.015 0.013 0.180 0.207 0.546** 0.507** 0.372* 1.000 0.420**
N 35 29 13 24 39 39 39 39 39
DBR2 CC 0.156 -0.217 0.496 0.317 0.578** 0.793** 0.270 0.420** 1.000
N 35 29 13 24 39 39 39 39 39
DOI: 10.7554/eLife.13664.014
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inexpensive and sustainable production method that is suitable to meet the constantly growing
demand for artemisinin and its derivatives has remained a grand challenge. Enormous breeding
efforts are currently underway to produce new varieties of A. annua that accumulate higher and
more consistent levels of the compound (Graham et al., 2010). However, as A. annua produces arte-
misinin only in a very small fraction of the leaf cells (the glandular trichomes) and its cultivation is
inefficient, slow and vulnerable to adverse environmental conditions, the development of a produc-
tion method that is independent of A. annua is highly desirable (Bryant et al., 2015). If accom-
plished in a high-biomass non-food/non-feed crop, this would provide a stable supply of the
feedstock that can be scaled up at will and at short notice, and take full advantage of the existing
agricultural infrastructure. In the course of this work, we have established tobacco as an efficient pro-
duction factory for artemisinic acid. Tobacco is a high-biomass crop, grown in large acreages, for
which alternative uses (that are unrelated to smoking) have long been sought. Since tobacco is well
suited for cultivation at high cropping densities and multiple harvests (4–5) per season are possible,
40 t of biomass can be obtained from a single acre of tobacco field at a cost of only around $100
per ton (http://tobacco.ces.ncsu.edu/wp-content/uploads/2012/07/tobacco-production-cost-2011-1.
pdf?fwd=no). Thus, with our best-performing COSTREL line, production levels of ~ 4.8 kg artemi-
sinic acid per acre can be obtained, suggesting that the current world demand (of ~ 100 t artemisi-
nin) can be met by cultivating tobacco on an area of ~200 km2, which is less than the area of the
city of Boston (assuming ~50% loss during extraction and conversion of artemisinic acid to artemisi-
nin; Paddon et al., 2013; Kopetzki et al., 2013).
Table 2. Correlation analysis of artemisinic compounds and transgenes introduced into transplastomic line Nt-AO3-1 by combinatorial
supertransformation. The levels of the artemisinic compounds amorpha-4,11-diene, artemisinic alcohol, dihydroartemisinic alcohol and
artemisinic acid, and the presence of the transgenes dxr, CYB5, ADH1, ALDH1 and DBR2 were correlated using Spearman’s method in
the 61 Nt-AO3-CS lines analyzed by genomic PCR in the T0 generation (see Figure 5—source data 1) using the SPSS software.
Dihydroartemisinic acid had to be excluded from this analysis, because it was detectable only in one of the Nt-AO3-CS lines in the T0
generation. Note that the negative correlation between artemisinic alcohol and artemisinic acid (Figure 5A,B) is restricted to those
lines that display increased artemisinic acid contents, and therefore is not statistically significant over all COSTREL lines analyzed (cf.
Figure 5—source data 1). CC: correlation coefficient. Positive values indicate positive correlations and negative values indicate









acid dxr CYB5 ADH1 ALDH1 DBR2
Amorpha-4,11-
diene
CC 1.000 0.363** 0.079 0.237 0.006 0.082 0.439** -0.032 0.049
N 60 58 39 59 60 60 60 60 60
Art. alcohol CC 0.363** 1.000 0.124 -0.081 -0.088 -0.119 0.086 0.026 -0.009
N 58 59 39 59 59 59 59 59 59
Dihydroart. alcohol CC 0.079 0.124 1.000 0.029 -0.169 0.153 0.306 0.195 0.219
N 39 39 39 39 39 39 39 39 39
Art. acid CC 0.237 -0.081 0.029 1.000 0.241 0.183 0.217 0.386** 0.141
N 59 59 39 60 60 60 60 60 60
dxr CC 0.006 -0.088 -0.169 0.241 1.000 0.153 0.224 0.415** 0.170
N 60 59 39 60 61 61 61 61 61
CYB5 CC 0.082 -0.119 0.153 0.183 0.153 1.000 0.185 0.322* 0.503**
N 60 59 39 60 61 61 61 61 61
ADH1 CC 0.439** 0.086 0.306 0.217 0.224 0.185 1.000 0.339** 0.252*
N 60 59 39 60 61 61 61 61 61
ALDH1 CC -0.032 0.026 0.195 0.386** 0.415** 0.322* 0.339** 1.000 0.444**
N 60 59 39 60 61 61 61 61 61
DBR2 CC 0.049 -0.009 0.219 0.141 0.170 0.503** 0.252* 0.444** 1.000
N 60 59 39 60 61 61 61 61 61
DOI: 10.7554/eLife.13664.015
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Figure 6. Chromatograms and mass spectra of amorpha-4,11-diene and artemisinic alcohol. Characteristic peaks for one specific fragment at the
expected retention time or index are displayed for each compound. (A) Amorpha-4,11-diene-specific mass feature 119 at a retention time of 1564 s.
This metabolite is present in all Nt-AO lines, and at slightly higher levels in lines Nt-AO2-1 and Nt-AO4-1. (B) Artemisinic alcohol-specific mass feature
202 at a retention index of 1784. The compound is present at similar levels in all Nt-AO lines. Both compounds are absent from the wild-type sample. In
addition to the chromatograms, the characteristic mass spectrum (m/z) of each compound is shown for the standard and for one of the artemisinic acid
operon lines. EPY224: yeast strain that produces amorpha-4,11-diene (Ro et al., 2006). One representative plant per line is depicted. Mass spectra and
mass features of trimethylsilylated artemisinic alcohol are shown.
DOI: 10.7554/eLife.13664.016
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Figure 7. Chromatograms and mass spectra of the artemisinic compounds artemisinic acid, dihydroartemisinic alcohol and dihydroartemisinic acid.
Characteristic peaks for one specific fragment at the expected retention index are shown for each compound. (A) Artemisinic acid-specific mass feature
Figure 7 continued on next page
Fuentes et al. eLife 2016;5:e13664. DOI: 10.7554/eLife.13664 15 of 26
Research article Biochemistry Plant biology
Whereas in A. annua the artemisinin biosynthetic pathway is confined to glandular trichomes, our
COSTREL tobacco lines produce artemisinic acid in chloroplasts and, thus, in the whole leaf.
Together with the absence of toxic effects of artemisinic acid on the chloroplast (Figure 5D; Fig-
ure 5—figure supplement 2), this offers great potential for further enhancement of the pathway by
addressing the bottlenecks that limit flux in our current best-performing lines. Furthermore, previous
transgenic work has shown that the redox environment in the cytosol of tobacco cells favors reduc-
tion of aldehydes to alcohols rather than their oxidation to acids, thus limiting the ability of the cyto-
solically located pathway to produce high quantities of artemisinic acid (Zhang et al., 2011). The
high levels of artemisinic acid achieved in this work by implementing the pathway into plastids sug-
gest that the chloroplast offers a more favorable redox milieu that allows the quantitative conversion
of artemisinic alcohol into artemisinic acid (Figure 5A,B). Although tobacco leaves also possess glan-
dular trichomes (where artemisinin is produced in A. annua), the trichomes in our COSTREL plants
are unlikely to accumulate large amounts of artemisinic acid. This is because transgene expression
from the plastid genome is generally very low in non-photosynthetic tissues and cell types. It can be
significantly enhanced by designing specific (chimeric) expression signals that confer high transgene
activity in non-green tissues (Zhang et al., 2012; Caroca et al., 2013), but the expression signals
used to drive our synthetic artemisinic acid operons (Figure 2) are not suitable to trigger efficient
gene expression in non-photosynthetic plastids.
The chloroplast represents an attractive site for engineering new metabolic pathways into plants.
Being the biosynthetic center of the plant cell, the chloroplast contains large pools of diverse metab-
olites that can be tapped. Expression of genes for metabolic enzymes from the plastid genome has
a number of attractions, including high expression levels, simple stacking of multiple transgenes in
synthetic operons (Lu et al., 2013; Gnanasekaran et al., 2016) and high-precision engineering via
homologous recombination (Maliga, 2004; Bock, 2015). Previously, plastid transformation was
employed to enhance endogenous metabolic pathways (Apel et al., 2009; Lu et al., 2013) or to
produce novel metabolites, such as ketocarotenoids and biopolymers (Hasunuma et al., 2008; Boh-
mert-Tatarev et al., 2011). Recently, two ER-resident cytochrome P450 enzymes of the dhurrin
pathway (a cyanogenic glucoside from sorghum) were successfully expressed from a synthetic
operon in tobacco chloroplasts (Gnanasekaran et al., 2016). Together with the third pathway
enzyme, a glucosyltransferse, the two P450 enzymes catalyzed the formation of dhurrin from tyro-
sine. The activity of the P450 enzymes was strictly light-dependent, indicating that the electrons
used come from the photosynthetic electron transport chain (Gnanasekaran et al., 2016). This sug-
gests that, at least when P450 enzymes are anchored to the thylakoid membrane, reduced ferre-
doxin can replace the NADPH-dependent native reductase (Gnanasekaran et al., 2016), thus
making the chloroplast a superb compartment for the implementation of secondary metabolic path-
ways that involve P450-catalyzed reactions.
By transplastomic introduction of the core pathway for artemisinic acid synthesis, our COSTREL
approach takes advantage of the stability and high efficiency of transgene expression from the plas-
tid genome (Maliga, 2004; Bock, 2015). Subsequent combinatorial supertransformation of the
nuclear genome with genes for auxiliary and regulatory factors then allows fine-tuning of the path-
way and optimization of metabolic flux by screening metabolic phenotypes of hundreds of trans-
genic lines that differ in the set of transgenes they harbor in the genome and the expression levels
of the transgenes (Zhu et al., 2008; Naqvi et al., 2009; 2010). Importantly, this approach requires
no prior knowledge about the contributions of the individual factors to metabolic flux and the opti-
mum expression strength of each transgene. Previous metabolic engineering work in microorgan-
isms has demonstrated that the success is often more dependent on achieving the optimum balance
Figure 7 continued
216 is shown at a retention index of 1850. This compound accumulates to higher levels in lines Nt-AO1-1 and Nt-AO3-1. (B) Dihydroartemisinic alcohol-
specific mass feature 162 at a retention index of 1789. The compound is present at high levels in COSTREL line Nt-AO2-CS95, but is absent from
transplastomic line Nt-AO2-1. (C) Dihydroartemisinic acid-specific mass feature 163 at a retention index of 1859. This compound accumulates in
COSTREL line Nt-AO3-CS180, but is absent from transplastomic line Nt-AO3-1. All compounds are absent from the wild-type sample. In addition to the
chromatograms, the characteristic mass spectrum of each compound is shown for the standard and for one of the artemisinic acid operon lines. Mass
spectra and mass features of trimethylsilylated artemisinic compounds are shown.
DOI: 10.7554/eLife.13664.017
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of enzyme activities than on the absolute levels of enzyme (over)expression (e.g., Peralta-
Yahya et al., 2012). The use of combinatorial supertransformation, therefore, provides a significant
advantage over the construction of large transformation vectors expressing multiple pathway genes,
because the great variation between transgenic events in (i) the transgene combination present, (ii)
the copy numbers of the individual transgenes and (iii) the absolute and relative expression strengths
of the transgenes (depending, e.g., on the integration site in the genome and the structure of the
transgenic locus) is likely to yield at least some events that harbor the optimum combination of trans-
genes and provide the right balance of enzyme activities. Moreover, the characterization of these
elite events can provide valuable information about pathway regulation, limiting steps and bottle-
necks that should be the target of future engineering and optimization efforts. In sum, our COSTREL
strategy provides a new synthetic biology tool that facilitates the efficient transfer of complex meta-
bolic pathways into new host organisms while, at the same time, maximizing the metabolic output.
Materials and methods
Plant material and growth conditions
Tobacco plants (Nicotiana tabacum cv. Petit Havana) were grown under sterile conditions on agar-
solidified MS medium (Murashige and Skoog, 1962) supplemented with 30 g/L sucrose. Genetically
modified plants were selected, propagated and rooted in the same medium containing additionally
500 mg/L spectinomycin (transplastomic plants) or 50 mg/L kanamycin (combinatorially supertrans-
formed plants). For sampling and seed production, plants were transferred to soil and grown under
standard greenhouse conditions.
Construction of transformation vectors
The synthetic operon constructs for chloroplast transformation (pAO1-4) are based on plastid trans-
formation vector pKP9 (Zhou et al., 2008). They all contain the four genes required for the canonical
artemisinic acid biosynthetic pathway in Artemisia annua: FPS (AF112881), ADS (AF138959),
CYP71AV1 (CYP, DQ268763) and CPR (DQ318192; Figure 1). The genes were codon optimized for
expression in the chloroplast and chemically synthesized (GeneArt, Regensburg, Germany). The four
genes were then assembled into synthetic operons as follows. The CYP71AV1 (CYP) gene was syn-
thesized with a Shine-Dalgarno (SD) sequence derived from the chloroplast rbcL gene and with the
flanking restriction sites NheI (at the 5’ end) and XbaI (at the 3’ end). The gene was cloned into pZF1
replacing the P24 gene (Zhou et al., 2008) and generating construct pZF83. pZF1 is an intermediate
cloning construct that contains the promoter from the rRNA operon from tobacco (Prrn), the leader
sequence from the gene 10 of bacteriophage T7 (T7 Lg10), the P24 capsid protein gene of HIV-1
and the terminator of the chloroplast rbcL gene (TrbcL; Zhou et al., 2008). A fragment containing
the rRNA operon promoter from Chlamydomonas reinhardtii (Cr Prrn), the T7 Lg10, the gfp gene,
the terminator of the atpA gene from the chloroplast genome of C. reinhardtii (Cr TatpA) and the
intercistronic expression element (IEE; Zhou et al., 2007) was excised with SacI and NheI from a
modified version of construct pDK139 in which the ClaI, SalI and XhoI restriction sites between Cr
TatpA and IEE were removed by XhoI/HindIII digestion and blunting of the overhanging ends by a
fill-in reaction with Klenow enzyme. pDK139 is a chloroplast transformation construct based on vec-
tor pHK20 (Kuroda and Maliga, 2001). The excised fragment was cloned into pZF83, replacing the
region spanning Prrn and T7 Lg10 and generating construct pZF84. Next, the FPS gene was synthe-
sized flanked by NdeI and PacI restriction sites at the 5’ and 3’ ends, respectively. The excised NdeI/
PacI restriction fragment was cloned into the identically digested pZF84, replacing the gfp gene and
giving rise to plasmid pZF85. The complete fragment from Cr Prrn to TrbcL was then cut out from
pZF85 with SacI and ClaI and ligated into chloroplast transformation vector pKP9 (Zhou et al.,
2008), producing clone pZF90. The ADS gene was synthesized (flanked by NcoI and EcoRV restric-
tion sites) and cloned into vector pKCZaphA-6, replacing the aphA-6 gene and giving rise to plasmid
pZF86. pKCZaphA-6 (Fleischmann et al., 2011) is an intermediate cloning construct that contains
the C. reinhardtii psbA promoter (Cr PpsbA), the C. reinhardtii psbA leader (Cr LpsbA), the aphA-6
gene for kanamycin resistance and the C. reinhardtii rbcL terminator (Cr TrbcL). Next, the terminator
of the tobacco rps16 gene (Trps16) was amplified by PCR with primers containing EcoRV and PstI
restriction sites at the 5’ and 3’ ends, respectively, and cloned into pZF86 digested with the same
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enzymes, generating vector pZF87. The CPR gene was synthesized as a PstI/SphI restriction frag-
ment with the rbcL SD sequence and an IEE element at its 5’ end. The fragment was cloned into
pZF87 digested with the same enzymes, giving rise to pZF88. Artemisinic acid operon constructs
pAO1 and pAO2 were generated by digesting pZF88 with ClaI (releasing the cassette containing
the ADS-CPR dicistron between Cr PpsbA and Cr TrbcL) and cloning this cassette into pZF90
digested with the same enzyme. In vector pAO1, the ADS-CPR cassette is integrated in sense orien-
tation, downstream of the FPS-CYP cassette, whereas in construct pAO2, the fragment is integrated
in antisense (Figure 2A). For generation of pAO3 and pAO4, the Cr PpsbA - Cr LpsbA fragment
was eliminated from pZF88 by digestion with MluI and NcoI and subsequently replaced by a PCR-
amplified Cr PpsbA - T7 Lg10 fragment obtained by digestion with the same enzymes, thus generat-
ing plasmid clone pZF89. pZF89 was then digested with ClaI and cloned into pZF90 in a similar way
as for generation of pAO1 and pAO2. Construct pAO3 originates from integration of the ADS-CPR
cassette in sense orientation, whereas pAO4 harbors the cassette in antisense orientation
(Figure 2A).
Constructs pCS1-5 for combinatorial supertransformation contain the genes dxr (BA000022) from
Synechocystis sp. and CYB5 (JQ582841.1), ADH1 (JF910157.1), ALDH1 (FJ809784.1) and DBR2
(EU704257.1) from A. annua. The genes were codon optimized for expression in the nucleus and
synthesized (Eurofins MWG Operon). The five constructs are derivatives of pUC18 and contain the
terminator from the nopaline synthase gene (Tnos), the transit peptide from RBCS and either the
35S promoter from the cauliflower mosaic virus (CaMV), the mannopine synthase gene promoter
from Agrobacterium tumefaciens (Pmas) or the ubiquitin-10 promoter from Arabidopsis thaliana
(PUBIQ10). To generate these constructs, the RBCS transit peptide (TP) was amplified by PCR with
primers introducing XbaI/XhoI, ApaI/XhoI or SpeI/XhoI restriction sites into the 5’ and 3’ ends of the
amplification product, respectively. The TP was then digested with the corresponding restriction
enzymes and cloned into a P35S-Tnos cassette (opened with XbaI/XhoI), a Pmas-Tnos cassette
(opened with ApaI/XhoI) and a PUBIQ10-Tnos cassette (opened with SpeI/XhoI), producing con-
structs pPF28, pPF29 and pPF30, respectively. Constructs pCS1 and pCS2 are derivatives of pPF28
and were generated by cloning the synthetic genes dxr and CYB5 into pPF28 as XhoI/SacI frag-
ments. Constructs pCS4 and pCS5 are derivatives of pPF29 and were obtained by cloning the syn-
thetic genes ALDH1 and DBR2 into pPF29 as XhoI/SacI fragments. Finally, construct pCS3 was
obtained in a similar way, by cloning the synthetic gene ADH1 into pPF30 as an XhoI/XmaI restriction
fragment.
The plasmid cocktail for combinatorial transformation was produced by mixing equal quantities
of constructs pCS1-5 (each at a concentration of 2 mg/mL) and plasmid pPH200 that contains the
nptII gene for kanamycin resistance between the CaMV 35S promoter and terminator.
Plastid transformation and selection of transplastomic tobacco plants
For chloroplast transformation, young leaves harvested from aseptically grown wild-type tobacco
plants were bombarded with gold particles covered with plasmid-DNA (pAO1-4) using the DuPont
PDS1000He biolistic gun. Spectinomycin-resistant shoots were selected on plant regeneration
medium with 500 mg/L spectinomycin (Svab and Maliga, 1993). Primary transformants were identi-
fied by Southern blot analysis and at least one additional regeneration round was performed to
obtain homoplasmic plants. Independently generated transplastomic lines are designated by the
construct number followed by the number of the individual line (e.g., Nt-AO1-2 stands for Nicotiana
tabacum plant obtained with construct pAO1, transplastomic line number 2). Homoplasmy was con-
firmed by Southern blot analyses and seed assays.
Combinatorial nuclear supertransformation and selection of transgenic
tobacco plants
Young leaves from transplastomic plants Nt-AO2-1 and Nt-AO3-1 grown under aseptic conditions
were harvested and bombarded with gold particles coated with a plasmid DNA mixture containing
pCS1-5 and pPH200 using the DuPont PDS1000He biolistic gun. Kanamycin-resistant shoots were
selected on plant regeneration medium containing 50 mg/L kanamycin. Resistant shoots were
rooted in the same medium, then transferred to soil and grown to maturity under standard green-
house conditions. Material from T0 plants was used for initial molecular analyses and preliminary
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metabolite profiling experiments. To generate standardized material for metabolite measurements
and molecular analysis of the T1 generation, seeds from candidate supertransformed lines were sur-
face-sterilized and sown on MS medium with 200 mg/L kanamycin. After three weeks, six green
(resistant) seedlings per line were transferred to soil and raised under standard greenhouse
conditions.
Plant growth and biomass measurements
Plant height and total leaf biomass were determined for six plants each of N. tabacum wild type
(wt), the transplastomic line Nt-AO3-1 and the progeny of four Nt-AO3-CS180 T1 lines. Measure-
ments were performed at two different stages. The first measurement was done when the wild-type
plants started to flower (’same age’). The second measurement was done when the Nt-AO3-1 and
Nt-AO3-CS180 plants started to flower (typically five days after the first measurement), to compen-
sate for the slightly delayed development of the transplastomic plants and the COSTREL plants. The
height was measured from the top of the pot to the top of the inflorescence. The total leaf biomass
(fresh weight, FW) was determined by weighing all leaves of an individual plant.
Isolation of nucleic acids
Total plant DNA was extracted from frozen leaf material by a CTAB-based protocol (Doyle and
Doyle, 1990). For total RNA extraction, samples of 300–400 mg of frozen powdered plant material
were extracted with the peqGOLD Trifast reagent (Peqlab GmbH, Erlangen, Germany), following
the manufacturer’s instructions. The RNA pellet was resuspended in 100 mL of RNase-free water and
Table 3. List of oligonucleotides used in this study. The reverse primers (_R) for amplification of the genes FPS, ADS, CYP and CPR
contain the sequence of the T7 promoter (bold) to facilitate in vitro transcription.
Gene Primer Sequence (5’fi3’) Purpose
dxr DXR_F CAACCTATGTACGTTGTTGGAGAAGAGGG qPCR
DXR_R CTGGAGCACCAGCAATCAATGTCTC
CYB5 CYB5_F CCAGGAGGAGATGAAGTTCTTTTGGCTG qPCR
CYB5_R GCTGGAGGAACGTAAGCTCTCTTCTTTG
ADH1 qADH1_F2 TCCAGGTCATGAAGGTGTTG qPCR
qADH1_R2 ATTGTCCACACTCACCAAGG
ALDH1 ALDH1_F CCTGTTTCTTTGGAATTGGGTGGTAAGTC qPCR
ALDH1_R CAGCAACACACATCTCACCTTTGTTAGTG
DBR2 DBR2_F GAGCAAGTTGAGGGTTGGAAGAAAGTTG qPCR
DBR2_R TAGAAGAGATAGGAGCAGCTCCACCTG
CYP CYP_qF CCTGAACCTTGGAGATTACC qPCR
CYP_qR GCCCATTTAGGAGAAGATACAAC
CPR CPR_qF CCTGTTGGAATGGGTGATG qPCR
CPR_qR CCTACAGCAGCAGTATAAGGAG
ACTIN qTac9actin f CCTGAGGTCCTTTTCCAACCA qPCR
qTac9actin r GGATTCCGGCAGCTTCCATT
FPS FPS_probe_F CCTGCTTTTGAATTTGATGATG RNA probe
FPS_probe_R TAATACGACTCACTATAGGGCGAAACCAACAAGGTTGTCC
ADS ADS_probe_F CTGAAGCTGTTGAAAGATGGTC RNA probe
ADS_probe_R TAATACGACTCACTATAGGGGGAGCAGATACAGCCCATTC
CYP CYP_probe_F TCCTCATCGAGGAGTACGAG RNA probe
CYP_probe_R TAATACGACTCACTATAGGGTTACAGGTCGTCCAGATCCAG
CPR CPR_probe_F ATGATTGGTCCTGGAACTGG RNA probe
CPR_probe_R TAATACGACTCACTATAGGGGCCATTCCTTTAGCATCTCC
DOI: 10.7554/eLife.13664.018
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mixed with 250 mL buffer RA1 from the NucleoSpin RNA Plant kit (Macherey-Nagel, Du¨ren, Ger-
many). 350 mL of 70% EtOH were mixed with the RNA solution, passed through the RNA-binding
column and purified following the protocol of the supplier. Finally, the RNA was eluted in 45 mL of
RNase-free water and stored at -80˚C until use.
cDNA synthesis
Prior to reverse transcription, isolated RNAs were tested for the presence of contaminating DNA by
a standard PCR using 1 ng of RNA as template. If no DNA amplification was observed, cDNA was
synthesized as follows. 1.5 mg of RNA were incubated with 1 mL of oligo(dT) primer (10 mM) and 1 mL
of dNTPs (10 mM) for 5 min at 65˚C. Then, 7 mL of a master mix were added (4 mL of 5x First Strand
buffer, 1 mL 0.1 M DTT, 40 U RNaseOUT and 200 U SuperScript III Reverse Transcriptase; Invitrogen,
Carlsbad, CA) and incubated for 1 hr at 50˚C, followed by an inactivation step of 15 min at 70˚C.
Alternatively, cDNA was synthesized using the QuantiTect Reverse Transcription kit (Qiagen, Hilden,
Germany) following the manufacturer’s instructions. The quality of the cDNA was tested by standard
PCR.
Quantitative real-time PCR (qRT-PCR)
Quantitative RT-PCR was performed in a LightCycler 480 (Roche, Mannheim, Germany) using cDNA
as template in 5 mL reactions containing 1 mL of each gene-specific primer (1.25 mM; Table 3), 2.5 mL
of the LightCycler 480 SYBR green I Master mix and 0.5 mL of a 1:50 cDNA dilution. Three biological
(independent plants) and three technical replicates per line were analyzed. The relative transcript
levels were determined using the formula (1+E)-DDCt where E is the binding efficiency of the primers
(Pfaffl, 2001). E was calculated from the slope of the expression level of each gene in a dilution
series of a given cDNA. Results were normalized to the mRNA levels of ACTIN as a housekeeping
gene (Table 3), and relative mRNA accumulation levels were calculated according to the delta-delta
Ct method. To identify the key genes involved in the increased levels of artemisinic acid in super-
transformed plants, the expression levels of each transgene (in all lines were it was present) were
compared by One-way ANOVA analysis (p<0.05). The results were expressed as a heat map, where
the darkest green color represents the highest expression level (brown: no expression).
Synthesis of hybridization probes and gel blot hybridizations
For Southern blot analysis, samples of 2–3 mg DNA were digested with BamHI, separated by electro-
phoresis in 0.8% agarose gels and transferred onto Hybond XL nylon membranes (GE Healthcare,
Little Chalfont, UK) by capillary blotting. For northern blot analysis, samples of 4–5 mg total RNA
were separated in denaturing formaldehyde-containing agarose gels (1.5%) and transferred onto
nylon membranes. As RFLP probe, a 550-bp fragment of the psaB gene was amplified by PCR using
primer pair P7247 / P7244 (Wurbs et al., 2007) and purified. The probe was labeled with [a32P]
dCTP by random priming (Multiprime DNA labeling kit; GE Healthcare). Probes for FPS, ADS, CYP
and CPR were generated by in vitro transcription and radioactive labeling with [a32P]UTP. PCR frag-
ments of 200–300 bp were amplified for each gene using specific primers (Table 3) that contain the
T7 promoter sequence in the reverse primer. Radiolabeled probes were generated by incubating 5
mL PCR product with 4 mL H2O, 2 mL 10x buffer, 3 mL of an equimolar mixture of ATP, CTP and GTP,
2 mL T7 RNA polymerase (15 U/mL) and 4 mL [a32P]UTP (40 mCi) for 30 min at 37˚C. Hybridizations
were performed overnight at 65˚C. Following standard washing steps, autoradiographic screens
were exposed to the membranes for 3–4 hr and then scanned in a Typhoon TRIO+ scanner (GE
Healthcare).
Cultivation of yeast reference strains
The following genetically engineered strains of Saccharomyces cerevisiae were used as reference
strains for artemisinic metabolites (Ro et al., 2008): (i) EPY300 (MATaa his3D1 leu2D0 lys2D0 ura3D0
PGAL1-tHMGR PGAL1-upc2-1 erg9::PMET3-ERG9 PGAL1-tHMGR PGAL1-ERG20; Ro et al., 2008),
a control strain that does not produce artemisinic compounds, (ii) EPY224 (EPY300 transformed with
plasmid pRS425-Leu::ADS; Ro et al., 2006), a strain that produces amorpha-4,11-diene, and (iii)
EPY302 (EPY300 transformed with plasmids pRS425-Leu::ADS and pESC-Ura::AMO/CPR; Ro et al.,
2006), a strain that produces artemisinic acid and artemisinic acid pathway intermediates. Plasmid
Fuentes et al. eLife 2016;5:e13664. DOI: 10.7554/eLife.13664 20 of 26
Research article Biochemistry Plant biology
pRS425-Leu::ADS complements the leucine auxotrophy and plasmid pESC-Ura::AMO/CPR comple-
ments the uracil auxotrophy of strain EPY300. The three yeast strains were kindly provided by Dr.
Jay D. Keasling (UC Berkley, USA). Yeast strains were maintained on solid synthetically defined (SD)
medium supplemented with 2% (w/v) sucrose and 0.002% (w/v) uracil for EPY224, and additionally
0.01% (w/v) leucine for EPY300. Induction of the synthesis of artemisinic compounds in strains
EPY224 and EPY302 was done by adding 1.8% (w/v) galactose and 1 mM methionine to liquid SD
medium and reducing the sucrose content to 0.2% (w/v). Yeast strains were incubated for 120 hr at
30˚C and 160 rpm, until they reached an OD600 of 1.4. Control strain EPY300 was incubated under
the same conditions in liquid SD medium supplemented with 2% (w/v) sucrose, 0.002% (w/v) uracil
and 0.01% (w/v) leucine.
GC-MS analyses
For GC-MS profiling of volatile organic compounds (VOCs), leaves of N. tabacum plants were col-
lected, immediately frozen in liquid nitrogen and processed in a cryogenic grinding robot (Labman,
North Yorkshire, UK). Aliquots of 500 ± 10 mg of frozen powdered leaf tissue were weighed in fro-
zen microcentrifuge tubes, and then transferred to frozen 20 mL head-space screw cap vials. The
powdered plant material was kept at 15˚C in the closed vials for at least 1 hr and then incubated for
10 min at 50˚C prior to VOC analysis. VOCs were sampled in a replicated randomized block
sequence design by solid phase micro extraction (SPME) using a StableFlexÔ SPME fiber with
65 mm polydimethylsiloxane/divinylbenzene coating (Supelco, Bellefonte, USA), and profiled as
described previously (Agudelo-Romero et al., 2015; 2013) using a DB-624 capillary column of 60 m
length, 0.25 mm internal diameter and 1.40 mm film thickness (Agilent Technologies Deutschland
GmbH, Waldbronn, Germany). VOCs were analyzed by gas chromatography coupled to electron
impact ionization/quadrupole mass spectrometry (GC-EI/QUAD-MS) using an Agilent 6890N24 gas
chromatograph connected to an Agilent 5975B VL mass spectrometer (Agilent Technologies, Bo¨blin-
gen, Germany). Data files were visually controlled, exported in NetCDF file format and baseline-cor-
rected using the Agilent ChemStation software and the MetAlign software (Lommen, 2009). Data
processing into a standardized numerical data matrix and compound identification were performed
using the TagFinder software (Luedemann et al., 2008). Criteria for manually supervised metabolite
identification were the presence of at least three specific and selective mass fragments and a reten-
tion time deviation <1.0%. The relative accumulation of amorpha-4,11-diene in VOC profiles of leaf
tissue was analyzed using the mass spectral intensity of specific and selective mass fragments
(Response) after normalization to fresh weight (Response/FW).
Amorpha-4,11-diene was identified in VOC profiles with the help of the reference substance
obtained from cultures of the genetically engineered yeast strain EPY224 (Ro et al., 2006). To this
end, the strain was grown in 25 mL of inducing SD medium for 120 hr at 30˚C under vigorous shak-
ing (160 rpm), until an OD600 of ~ 1.4 was reached. Additionally, control strain EPY300 was grown in
25 mL of SD medium supplemented with 2% (w/v) sucrose, 0.002% (w/v) uracil and 0.01% (w/v) leu-
cine under the same conditions. Amorpha-4,11-diene was identified by differential display of 1 mL
cell suspensions in 20 mL head-space screw cap vials comparing the VOC profiles of the compounds
obtained from strain EPY224 with those from control strain EPY300, and analysis of the main differ-
ential VOC. VOC profiles obtained from leaf material of A. annua were used to further validate the
identification of amorpha-4,11-diene. Amorpha-4,11-diene present in the VOCs of tobacco leaf
material from transplastomic and combinatorially supertransformed lines was annotated by mass
spectral (m/z) and retention time matching to the reference data in the Golm Metabolome Database
(GMD, http://gmd.mpimp-golm.mpg.de/; Kopka et al., 2005). For compound information and ref-
erence data, see the GMD entry for amorpha-4,11-diene (GMD identifier: A149010; http://gmd.
mpimp-golm.mpg.de/search.aspx). The retention time of amorpha-4,11-diene in the VOC analysis
(Agudelo-Romero et al., 2015) of tobacco plant samples was on average 1563 s, with less than 1%
deviation between independent experiments. The specific fragments used for verification of the
identity of the compound in complex samples were m/z 93, 105, 119, 133, 189 and 204 (Figure 6A).
For preparation and GC-MS profiling of lipophilic saponification products from total leaf tissue
containing artemisinic acid and/or intermediates of artemisinic acid biosynthesis, aliquots of 150 ± 5
mg of frozen powdered N. tabacum leaves were mixed with 500 mL of 2 N KOH/methanol, and incu-
bated at 70˚C for 1 hr with gentle shaking (at 800 rpm). After acidification of the saponified samples
with 100 mL of 12 M HCl, 300 mL of hexane were added and the samples were vortexed for 1 min.
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After centrifugation for 5 min at 14,000 rpm, 200 mL of the hexane extract were transferred into a
clean microcentrifuge tube and concentrated under a mild N2 flow to near dryness. Samples were
manually trimethylsilylated. Trimethylsilylation was performed by adding 50 mL of a mixture of N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA) and an n-alkane standard in hexane (7:1, v/v) followed
by incubation at 37˚C for 30 min with gentle shaking (800 rpm). Metabolite profiling was performed
as detailed previously (Erban et al., 2007) by gas chromatography coupled to electron impact ioni-
zation/time-of-flight mass spectrometry (GC-EI/TOF-MS) using an Agilent 6890N24 gas chromato-
graph (Agilent Technologies) connected to a Pegasus III time-of-flight mass spectrometer (LECO
Instrumente GmbH, Mo¨nchengladbach, Germany). Retention indices were calibrated in the range
relevant for the intermediates of artemisinic acid biosynthesis by addition of a C15/C18/C19 alkane
reference mixture to each sample (Strehmel et al., 2008). Chromatograms were acquired, visually
controlled, baseline-corrected and exported in NetCDF file format using the ChromaTOF software
(Version 4.22; LECO, St. Joseph, USA). Data analysis of GC-EI/TOF-MS profiles of lipophilic saponifi-
cation products was performed as described for the VOC analysis. Relative quantification of the
intermediates of artemisinic acid biosynthesis was performed by calculating normalized responses/
FW values using the response of the C18 n-alkane and the fresh weight of the sample.
Intermediates of artemisinic acid biosynthesis were initially identified by comparing GC-EI/TOF-
MS profiles from yeast strain EPY224 (synthesizing amorpha-4,11-diene) to those of yeast strain
EPY302 (synthesizing artemisinic acid and also accumulating all pathway intermediates) and control
strain EPY300 (that does not express any of the pathway enzymes). Strain EPY302 was cultured in
the same way as strain EPY224, but without addition of uracil. All extractions were performed in
duplicate omitting saponification. One of the two sample sets was trimethylsilylated as described
above, while the other sample set remained non-derivatized. Non-derivatized samples from yeast
were compared to trimethylsilylated samples to unambiguously link the non-derivatized soluble met-
abolic intermediates of artemisinic acid (A188031) and artemisinic alcohol (A177023) to their respec-
tive trimethylsilylated analytes (artemisinic acid 1TMS, A185023; artemisinic alcohol 1TMS,
A178029). Dihydroartemisinic alcohol 1TMS (A179026) and dihydroartemisinic acid 1TMS (A186033)
were identified after trimethylsilylation. To further validate the identity of the artemisinic com-
pounds, the trimethylsilylated and non-derivatized GC-EI/TOF-MS profiles from yeast were com-
pared to equivalently processed leaf material of A. annua. Finally, GC-EI/TOF-MS profiles from
authenticated reference compounds (kindly provided by Andreas Pallidis and Dr. Alexander R. van
der Krol, Wageningen University, The Netherlands) were used to unambiguously confirm identifica-
tion of artemisinic acid (AA), artemisinic aldehyde (AAA), artemisinic alcohol (AAOH), dihydroartemi-
sinic acid (DHAA), dihydroartemisinic aldehyde (DHAAA) and dihydroartemisinic alcohol (DHAAOH).
Artemisinic alcohol, dihydroartemisinic alcohol, dihydroartemisinic acid and artemisinic acid were
identified as trimethylsilylated chemical derivatives in complex profiles according to their mass spec-
trum (m/z) and retention time index relative to the C15/C18/C19 n-alkanes, using reference data from
the Golm Metabolome Database. Guidelines for manually supervised metabolite identification were
the presence of at least 3 specific mass fragments per compound and a retention index deviation
<1.0% (Strehmel et al., 2008). The average retention index of artemisinic alcohol (1TMS) was 1785
and the specific fragments used for verification were m/z 91, 105, 119, 132, 162, 187 and 202. The
average retention index of dihydroartemisinic alcohol (1TMS) was 1789 and the specific fragments
used for verification were m/z 91, 105, 162, 189 and 204. The average retention index of dihydroar-
temisinic acid (1TMS) was 1859 and the specific fragments used for verification were m/z 91, 105,
119, 130, 162, 163, 293 and 308. The average retention index of artemisinic acid (1TMS) was 1851
and the specific fragments used for verification were m/z 91, 105, 119, 188, 216, 291 and 306 (Fig-
ures 6 and 7). Retention indices of each compound showed a deviation of less than 1% in all meas-
urements performed. For quantification purposes, the most abundant and specific among the
selective mass features of each artemisinic metabolite was chosen, i.e., m/z 162 or 202 for artemi-
sinic alcohol (Figure 6B), m/z 162 or 204 for dihydroartemisinic alcohol (Figure 7B), m/z 163 for
dihydroartemisinic acid (Figure 7C), and m/z 188 or 216 for artemisinic acid (Figure 7A).
For absolute quantification of artemisinic acid, we first determined the percentage of recovery of
artemisinic acid spiked into wild-type tobacco leaf tissue samples in comparison to the recovery of
pure artemisinic acid processed without saponification and in the absence of leaf material. To this
end, 150 ± 5 mg of powdered frozen leaf material from N. tabacum was mixed with 10 mL of an arte-
misinic acid standard of known concentration (2 mg/mL in methanol) and subjected to the
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saponification protocol. The matrix-free artemisinic acid standard was prepared by dissolving 2 mg
of artemisinic acid powder (Apin Chemicals, Oxon, UK) in 1 mL of methanol. All spiked samples
were prepared and measured in six replicates and compared to the non-saponified matrix-free arte-
misinic acid reference samples. The average of the artemisinic acid response values obtained from
the reference samples was set to 100%, and the percentage of recovery of artemisinic acid from the
leaf tissue matrix after saponification was calculated to be 66 ± 16%. This value was used to correct
for the final amount of total artemisinic acid in saponified extracts from plant samples. The artemi-
sinic acid concentration in transplastomic and combinatorially supertransformed plants was cali-
brated using a dilution series of the commercial non-saponified standard. GC-EI/TOF-MS analysis
was as described above. The final quantification of artemisinic acid in line Nt-AO3-CS180 was done
as described above except that, due to the high amounts, only 1/10 of the standard extract volume
was used.
For identification of artemisinin or degradation products of artemisinin, aliquots of 1.2 ± 0.01 g of
frozen powdered leaf tissue were placed in 20 mL head-space screw cap vials, mixed with 3.6 mL
hexane and incubated for 1 hr in a water bath at 69˚C. The tubes were shortly vortexed and opened
every 10 min to release the vapor pressure. Samples were then centrifuged for 5 min at 14,000 rpm.
300 mL of the hexane extracts were transferred to 1.1 mL Chromacol vials and reduced to 50 mL
under a mild flow of N2. For identification of artemisinin or its degradation products, 500, 1000 or
2500 ng of an artemisinin standard (1 mg/mL; Sigma-Aldrich, Steinheim, Germany) were subjected
to the same procedure. GC-EI/TOF-MS profiling was performed as described for soluble metabolites
using the whole tissue saponification protocol. As reported previously, only the degradation prod-
ucts of artemisinin (peaks A and B; Sipahimalani et al., 1991), were detected, likely due to thermal
instability of artemisinin. Peaks A and B were only detected in samples that contained the artemisinin
reference compound, but not in any of the plant samples.
UPLC analysis of isoprenoids
For UPLC analysis of pigments, samples of 40 ± 2 mg of frozen powdered leaf tissue were extracted
with 500 mL HPLC grade acetone. A stainless steel ball was added to the mixture and the samples
incubated for 20 min at 30˚C and 1,400 rpm in the dark. After centrifugation for 5 min at
12,000 rpm and 4˚C, the upper phase was collected in a new microcentrifuge tube and stored on ice
in darkness. The acetone extraction was repeated two more times, using 250 mL of acetone each
time and combining the three upper phases. Following centrifugation for 5 min at 12,000 rpm and
4˚C to precipitate any remaining insoluble material, 600 mL of the acetone extracts were transferred
to 9 mm glass vials. Samples were analyzed using a Waters UPLC Class H (Milford, USA) equipped
with an autosampler, Quaternary Solvent Manager, and el PDA detector. Pigments were separated
in a Waters ACQUITY UPLC BEH C18 1.7 mm C18 2.1  50 mm column at 28˚C, using UPLC solutions
A and B. Elution was carried out at a flow rate of 0.5 mL/min with the following gradient: 100–0% of
solution A from 0 to 5 min, 100% solution B from 5 to 6 min, 0–100% solution A from 6 to 6.5 min,
and 100% solution A from 6.5 to 7.5 min. Carotenoids were detected at 450 nm and chlorophylls at
640 nm. Three biological replicates (i.e., independent plants) per condition were measured and data
were analyzed with the Empower 3 software.
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